IDEAYA Biosciences (IDYA) Operating Leases (2019 - 2025)
Historic Operating Leases for IDEAYA Biosciences (IDYA) over the last 7 years, with Q3 2025 value amounting to $26.9 million.
- IDEAYA Biosciences' Operating Leases rose 4320.6% to $26.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.9 million, marking a year-over-year increase of 4320.6%. This contributed to the annual value of $18.9 million for FY2024, which is 157760.0% up from last year.
- Latest data reveals that IDEAYA Biosciences reported Operating Leases of $26.9 million as of Q3 2025, which was up 4320.6% from $26.3 million recorded in Q2 2025.
- In the past 5 years, IDEAYA Biosciences' Operating Leases ranged from a high of $26.9 million in Q3 2025 and a low of $611000.0 during Q2 2023
- Over the past 5 years, IDEAYA Biosciences' median Operating Leases value was $3.3 million (recorded in 2021), while the average stood at $8.3 million.
- Its Operating Leases has fluctuated over the past 5 years, first plummeted by 7624.42% in 2023, then soared by 157760.0% in 2024.
- Quarter analysis of 5 years shows IDEAYA Biosciences' Operating Leases stood at $3.5 million in 2021, then plummeted by 53.73% to $1.6 million in 2022, then tumbled by 30.17% to $1.1 million in 2023, then skyrocketed by 1577.6% to $18.9 million in 2024, then soared by 42.62% to $26.9 million in 2025.
- Its Operating Leases stands at $26.9 million for Q3 2025, versus $26.3 million for Q2 2025 and $25.7 million for Q1 2025.